BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeglis BM, Houghton JL, Evans MJ, Viola-Villegas N, Lewis JS. Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals. Inorg Chem 2014;53:1880-99. [PMID: 24313747 DOI: 10.1021/ic401607z] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Bredack C, Edelmann MR, Borroni E, Gobbi LC, Honer M. Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines. Pharmaceuticals (Basel) 2022;15. [PMID: 36558900 DOI: 10.3390/ph15121445] [Reference Citation Analysis]
2 Wagner L, Kenzhebayeva B, Dhaini B, Boukhlef S, Moussaron A, Mordon S, Frochot C, Collet C, Acherar S. Folate-based radiotracers for nuclear imaging and radionuclide therapy. Coordination Chemistry Reviews 2022;470:214702. [DOI: 10.1016/j.ccr.2022.214702] [Reference Citation Analysis]
3 Igarashi C, Matsumoto H, Takahashi M, Hihara F, Tachibana T, Zhang M, Kurihara H, Higashi T, Yoshii Y. Identification and quantitative structure–activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [64Cu]Cu-ATSM. Nuclear Medicine and Biology 2022;108-109:10-5. [DOI: 10.1016/j.nucmedbio.2022.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Xu J, Cai F, Luo Z, Fan W, Dai J, Cui J, Li S, Geng C, Zheng Q, Wang Z, Tang X. Design, synthesis, and preclinical evaluation of a novel bifunctional macrocyclic chelator for theranostics of cancers. Eur J Nucl Med Mol Imaging. [DOI: 10.1007/s00259-022-05750-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Canziani L, Marenco M, Cavenaghi G, Manfrinato G, Taglietti A, Girella A, Aprile C, Pepe G, Lodola L. Chemical and Physical Characterisation of Macroaggregated Human Serum Albumin: Strength and Specificity of Bonds with 99mTc and 68Ga. Molecules 2022;27:404. [PMID: 35056719 DOI: 10.3390/molecules27020404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Keinänen O, Nash AG, Sarrett SM, Sarparanta M, Lewis JS, Zeglis BM. Novel Positron-Emitting Radiopharmaceuticals. Nuclear Oncology 2022. [DOI: 10.1007/978-3-031-05494-5_87] [Reference Citation Analysis]
7 Keinänen O, Nash AG, Sarrett SM, Sarparanta M, Lewis JS, Zeglis BM. Novel Positron-Emitting Radiopharmaceuticals. Nuclear Oncology 2022. [DOI: 10.1007/978-3-319-26067-9_87-3] [Reference Citation Analysis]
8 Hermann P, Kotek J, Kubíček V. Ten-Membered Rings or Lager With One or More Nitrogen Atoms. Comprehensive Heterocyclic Chemistry IV 2022. [DOI: 10.1016/b978-0-12-818655-8.00128-1] [Reference Citation Analysis]
9 Mular A, Shanzer A, Kozłowski H, Hubmann I, Misslinger M, Krzywik J, Decristoforo C, Gumienna-Kontecka E. Cyclic Analogs of Desferrioxamine E Siderophore for 68Ga Nuclear Imaging: Coordination Chemistry and Biological Activity in Staphylococcus aureus. Inorg Chem 2021;60:17846-57. [PMID: 34783539 DOI: 10.1021/acs.inorgchem.1c02453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 De Feo MS, Pontico M, Frantellizzi V, Corica F, De Cristofaro F, De Vincentis G. 89Zr-PET imaging in humans: a systematic review. Clin Transl Imaging. [DOI: 10.1007/s40336-021-00462-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Pazderová L, Kubíček V, Kotek J, Hermann P. 1,4,7‐Triazacyclononane (tacn) with N,N ′‐bridging methylene‐bis(phosphinic acid) group and its complexes. Z Anorg Allg Chem 2021;647:1261-1268. [DOI: 10.1002/zaac.202100107] [Reference Citation Analysis]
12 Sarrett SM, Keinänen O, Dayts EJ, Dewaele-Le Roi G, Rodriguez C, Carnazza KE, Zeglis BM. Inverse electron demand Diels-Alder click chemistry for pretargeted PET imaging and radioimmunotherapy. Nat Protoc 2021;16:3348-81. [PMID: 34127865 DOI: 10.1038/s41596-021-00540-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Pazderová L, David T, Kotek J, Kubíček V, Hermann P. Complexes of cyclen side-bridged with a methylene-bis(phosphinate) group. Polyhedron 2021;196:114994. [DOI: 10.1016/j.poly.2020.114994] [Reference Citation Analysis]
14 Qi C, Wang X, Chen Z, Xiang S, Wang T, Feng H, Tang BZ. Organometallic AIEgens for biological theranostics. Mater Chem Front 2021;5:3281-97. [DOI: 10.1039/d0qm01130d] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
15 Vanbrocklin HF. PET Radiochemistry. Molecular Imaging 2021. [DOI: 10.1016/b978-0-12-816386-3.00027-2] [Reference Citation Analysis]
16 Holland JP. The Radiochemistry of Zirconium. Handbook of Radiopharmaceuticals 2020. [DOI: 10.1002/9781119500575.ch11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Li Z, Guo T, Lu J, Yang Z, Zhang M, Geng Z, Wang Z. Targeted copper supplementation oriented theranostic for fluorescence and 19F NMR detection of tumors. Chem Commun (Camb) 2020;56:11589-92. [PMID: 32914792 DOI: 10.1039/d0cc05089j] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
18 Mizuno Y, Komatsu N, Uehara T, Shimoda Y, Kimura K, Arano Y, Akizawa H. Aryl isocyanide derivative for one-pot synthesis of purification-free 99mTc-labeled hexavalent targeting probe. Nucl Med Biol 2020;86-87:30-6. [PMID: 32470868 DOI: 10.1016/j.nucmedbio.2020.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Alnahwi AH, Ait-Mohand S, Dumulon-Perreault V, Dory YL, Guérin B. Promising Performance of 4HMS, a New Zirconium-89 Octadendate Chelator. ACS Omega 2020;5:10731-9. [PMID: 32455192 DOI: 10.1021/acsomega.0c00207] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Moroz A, Wang YH, Sharib JM, Wei J, Zhao N, Huang Y, Chen Z, Martinko AJ, Zhuo J, Lim SA, Zhang LH, Seo Y, Carlin S, Leung KK, Collisson EA, Kirkwood KS, Wells JA, Evans MJ. Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer. Clin Cancer Res 2020;26:3608-15. [PMID: 32341034 DOI: 10.1158/1078-0432.CCR-20-0268] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
21 MacPherson DS, Fung K, Cook BE, Francesconi LC, Zeglis BM. A brief overview of metal complexes as nuclear imaging agents. Dalton Trans 2019;48:14547-65. [PMID: 31556418 DOI: 10.1039/c9dt03039e] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
22 Choi PS, Lee JY, Vyas CK, Yang SD, Kim SW, Park JH. One-pot synthesis of chelator-free 89Zr-incorporated hierarchical hematite nanoclusters for in vitro evaluation. J Nanopart Res 2019;21. [DOI: 10.1007/s11051-019-4680-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kadakia RT, Xie D, Martinez D, Yu M, Que EL. A dual-responsive probe for detecting cellular hypoxia using 19F magnetic resonance and fluorescence. Chem Commun (Camb) 2019;55:8860-3. [PMID: 31219109 DOI: 10.1039/c9cc00375d] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
24 Walke GR, Ruthstein S. Does the ATSM-Cu(II) Biomarker Integrate into the Human Cellular Copper Cycle? ACS Omega 2019;4:12278-85. [PMID: 31460344 DOI: 10.1021/acsomega.9b01748] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
25 Okoye NC, Baumeister JE, Najafi Khosroshahi F, Hennkens HM, Jurisson SS. Chelators and metal complex stability for radiopharmaceutical applications. Radiochimica Acta 2019;107:1087-120. [DOI: 10.1515/ract-2018-3090] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
26 Toporivska Y, Gumienna-Kontecka E. The solution thermodynamic stability of desferrioxamine B (DFO) with Zr(IV). J Inorg Biochem 2019;198:110753. [PMID: 31229836 DOI: 10.1016/j.jinorgbio.2019.110753] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
27 Imberti C, Chen YL, Foley CA, Ma MT, Paterson BM, Wang Y, Young JD, Hider RC, Blower PJ. Tuning the properties of tris(hydroxypyridinone) ligands: efficient 68Ga chelators for PET imaging. Dalton Trans 2019;48:4299-313. [PMID: 30860215 DOI: 10.1039/c8dt04454f] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
28 Mizuno Y, Uehara T, Jen C, Akizawa H, Arano Y. The synthesis of a 99m Tc-labeled tetravalent targeting probe upon isonitrile coordination to 99m Tc I for enhanced target uptake in saturable systems. RSC Adv 2019;9:26126-35. [DOI: 10.1039/c9ra04311j] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Collier TL, Dahl K, Stephenson NA, Holland JP, Riley A, Liang SH, Vasdev N. Recent applications of a single quadrupole mass spectrometer in 11C, 18F and radiometal chemistry. J Fluor Chem 2018;210:46-55. [PMID: 30410189 DOI: 10.1016/j.jfluchem.2018.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
30 Vaudon J, Frealle L, Audiger G, Dutillly E, Gervais M, Sursin E, Ruggeri C, Duval F, Bouchetou M, Bombard A, Da Silva I. First Steps at the Cyclotron of Orléans in the Radiochemistry of Radiometals: 52Mn and 165Er. Instruments 2018;2:15. [DOI: 10.3390/instruments2030015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
31 Läppchen T, Kiefer Y, Holland JP, Bartholomä MD. In vitro and in vivo evaluation of the bifunctional chelator NODIA-Me in combination with a prostate-specific membrane antigen targeting vector. Nuclear Medicine and Biology 2018;60:45-54. [DOI: 10.1016/j.nucmedbio.2018.03.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
32 Carter LM, Poty S, Sharma SK, Lewis JS. Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy-Model, vector, and radionuclide selection. J Labelled Comp Radiopharm 2018;61:611-35. [PMID: 29412489 DOI: 10.1002/jlcr.3612] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
33 McKnight BN, Viola-Villegas NT. 89 Zr-ImmunoPET companion diagnostics and their impact in clinical drug development. J Labelled Comp Radiopharm 2018;61:727-38. [PMID: 29341222 DOI: 10.1002/jlcr.3605] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
34 Weinmann C, Holland JP, Läppchen T, Scherer H, Maus S, Stemler T, Bohnenberger H, Ezziddin S, Kurz P, Bartholomä MD. Optimized synthesis and indium complex formation with the bifunctional chelator NODIA-Me. Org Biomol Chem 2018;16:7503-12. [DOI: 10.1039/c8ob01981a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
35 Mcinnes LE, Rudd SE, Donnelly PS. Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation. Coordination Chemistry Reviews 2017;352:499-516. [DOI: 10.1016/j.ccr.2017.05.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 6.5] [Reference Citation Analysis]
36 Nawaz S, Mullen GED, Sunassee K, Bordoloi J, Blower PJ, Ballinger JR. Simple, mild, one-step labelling of proteins with gallium-68 using a tris(hydroxypyridinone) bifunctional chelator: a 68Ga-THP-scFv targeting the prostate-specific membrane antigen. EJNMMI Res 2017;7:86. [PMID: 29067565 DOI: 10.1186/s13550-017-0336-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
37 Comba P, Jermilova U, Orvig C, Patrick BO, Ramogida CF, Rück K, Schneider C, Starke M. Octadentate Picolinic Acid-Based Bispidine Ligand for Radiometal Ions. Chem Eur J 2017;23:15945-56. [DOI: 10.1002/chem.201702284] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
38 Heskamp S, Raavé R, Boerman O, Rijpkema M, Goncalves V, Denat F. 89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry. Bioconjug Chem 2017;28:2211-23. [PMID: 28767228 DOI: 10.1021/acs.bioconjchem.7b00325] [Cited by in Crossref: 113] [Cited by in F6Publishing: 117] [Article Influence: 18.8] [Reference Citation Analysis]
39 Guillou A, Lima LMP, Roger M, Esteban‐gómez D, Delgado R, Platas‐iglesias C, Patinec V, Tripier R. 1,4,7‐Triazacyclononane‐Based Bifunctional Picolinate Ligands for Efficient Copper Complexation. Eur J Inorg Chem 2017;2017:2435-43. [DOI: 10.1002/ejic.201700176] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
40 Tieu W, Lifa T, Katsifis A, Codd R. Octadentate Zirconium(IV)-Loaded Macrocycles with Varied Stoichiometry Assembled From Hydroxamic Acid Monomers using Metal-Templated Synthesis. Inorg Chem 2017;56:3719-28. [DOI: 10.1021/acs.inorgchem.7b00362] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
41 Whittenberg JJ, Li H, Zhou H, Koziol J, Desai AV, Reichert DE, Kenis PJA. “Click Chip” Conjugation of Bifunctional Chelators to Biomolecules. Bioconjugate Chem 2017;28:986-94. [DOI: 10.1021/acs.bioconjchem.6b00703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
42 Baum RP, Singh A, Benešová M, Vermeulen C, Gnesin S, Köster U, Johnston K, Müller D, Senftleben S, Kulkarni HR, Türler A, Schibli R, Prior JO, van der Meulen NP, Müller C. Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152 Tb-DOTATOC. Dalton Trans 2017;46:14638-46. [DOI: 10.1039/c7dt01936j] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
43 Price TW, Gallo J, Kubíček V, Böhmová Z, Prior TJ, Greenman J, Hermann P, Stasiuk GJ. Amino acid based gallium-68 chelators capable of radiolabeling at neutral pH. Dalton Trans 2017;46:16973-82. [DOI: 10.1039/c7dt03398b] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
44 Shaffer TM, Harmsen S, Khwaja E, Kircher MF, Drain CM, Grimm J. Stable Radiolabeling of Sulfur-Functionalized Silica Nanoparticles with Copper-64. Nano Lett 2016;16:5601-4. [PMID: 27464258 DOI: 10.1021/acs.nanolett.6b02161] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
45 Demoin DW, Wyatt LC, Edwards KJ, Abdel-Atti D, Sarparanta M, Pourat J, Longo VA, Carlin SD, Engelman DM, Andreev OA, Reshetnyak YK, Viola-Villegas N, Lewis JS. PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization Study. Bioconjug Chem 2016;27:2014-23. [PMID: 27396694 DOI: 10.1021/acs.bioconjchem.6b00306] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
46 Truillet C, Thomas E, Lux F, Huynh LT, Tillement O, Evans MJ. Synthesis and Characterization of (89)Zr-Labeled Ultrasmall Nanoparticles. Mol Pharm 2016;13:2596-601. [PMID: 27266800 DOI: 10.1021/acs.molpharmaceut.6b00264] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
47 Watanabe H, Kawasaki A, Sano K, Ono M, Saji H. Synthesis and evaluation of copper-64 labeled benzofuran derivatives targeting β-amyloid aggregates. Bioorg Med Chem 2016;24:3618-23. [PMID: 27301677 DOI: 10.1016/j.bmc.2016.06.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
48 Pratt EC, Shaffer TM, Grimm J. Nanoparticles and radiotracers: advances toward radionanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2016;8:872-90. [PMID: 27006133 DOI: 10.1002/wnan.1402] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
49 Makris G, Radford L, Gallazzi F, Jurisson S, Hennkens H, Papagiannopoulou D. Synthesis and evaluation of fac-[99mTc/Re(CO)3]+ complexes with a new (N,S,N) bifunctional chelating agent: The first example of a fac-[Re(CO)3(N,S,N-sst2-ANT)] complex bearing a somatostatin receptor antagonist peptide. Journal of Organometallic Chemistry 2016;805:100-7. [DOI: 10.1016/j.jorganchem.2016.01.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
50 Xie D, King TL, Banerjee A, Kohli V, Que EL. Exploiting Copper Redox for 19 F Magnetic Resonance-Based Detection of Cellular Hypoxia. J Am Chem Soc 2016;138:2937-40. [DOI: 10.1021/jacs.5b13215] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 9.1] [Reference Citation Analysis]
51 Chakravarty R, Chakraborty S, Ram R, Nair KV, Rajeswari A, Sarma HD, Dash A. Palliative care of bone pain due to skeletal metastases: Exploring newer avenues using neutron activated (45)Ca. Nucl Med Biol 2016;43:140-9. [PMID: 26872438 DOI: 10.1016/j.nucmedbio.2015.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
52 Rudd SE, Roselt P, Cullinane C, Hicks RJ, Donnelly PS. A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies. Chem Commun 2016;52:11889-92. [DOI: 10.1039/c6cc05961a] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 9.0] [Reference Citation Analysis]
53 Banger KK. Gallium: Inorganic Chemistry. Encyclopedia of Inorganic and Bioinorganic Chemistry 2015. [DOI: 10.1002/9781119951438.eibc0072.pub2] [Reference Citation Analysis]
54 Lapi SE, Lewis JS, Dehdashti F. Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone). Semin Nucl Med 2015;45:177-85. [PMID: 25704389 DOI: 10.1053/j.semnuclmed.2014.10.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
55 David T, Kubíček V, Gutten O, Lubal P, Kotek J, Pietzsch H, Rulíšek L, Hermann P. Cyclam Derivatives with a Bis(phosphinate) or a Phosphinato–Phosphonate Pendant Arm: Ligands for Fast and Efficient Copper(II) Complexation for Nuclear Medical Applications. Inorg Chem 2015;54:11751-66. [DOI: 10.1021/acs.inorgchem.5b01791] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
56 Andrzejewska A, Nowakowski A, Janowski M, Bulte JW, Gilad AA, Walczak P, Lukomska B. Pre- and postmortem imaging of transplanted cells. Int J Nanomedicine 2015;10:5543-59. [PMID: 26366076 DOI: 10.2147/IJN.S83557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
57 Ma MT, Cullinane C, Imberti C, Baguña Torres J, Terry SY, Roselt P, Hicks RJ, Blower PJ. New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One-Step Labeling and PET Imaging with (68)Ga(3.). Bioconjug Chem 2016;27:309-18. [PMID: 26286399 DOI: 10.1021/acs.bioconjchem.5b00335] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
58 Roux A, Nonat AM, Brandel J, Hubscher-bruder V, Charbonnière LJ. Kinetically Inert Bispidol-Based Cu(II) Chelate for Potential Application to 64/67 Cu Nuclear Medicine and Diagnosis. Inorg Chem 2015;54:4431-44. [DOI: 10.1021/acs.inorgchem.5b00207] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
59 Sturzbecher-Hoehne M, Choi TA, Abergel RJ. Hydroxypyridinonate complex stability of group (IV) metals and tetravalent f-block elements: the key to the next generation of chelating agents for radiopharmaceuticals. Inorg Chem 2015;54:3462-8. [PMID: 25799124 DOI: 10.1021/acs.inorgchem.5b00033] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
60 Hayes TR, Lyon PA, Barnes CL, Trabue S, Benny PD. Influence of functionalized pyridine ligands on the radio/chemical behavior of [M(I)(CO)3](+) (M = Re and (99m)Tc) 2 + 1 complexes. Inorg Chem 2015;54:1528-34. [PMID: 25590985 DOI: 10.1021/ic502520x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
61 Brasse D, Nonat A. Radiometals: towards a new success story in nuclear imaging? Dalton Trans 2015;44:4845-58. [DOI: 10.1039/c4dt02911a] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 5.3] [Reference Citation Analysis]
62 Zeglis BM, Davis CB, Abdel-Atti D, Carlin SD, Chen A, Aggeler R, Agnew BJ, Lewis JS. Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging. Bioconjug Chem 2014;25:2123-8. [PMID: 25418333 DOI: 10.1021/bc500499h] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 5.8] [Reference Citation Analysis]
63 Price EW, Zeglis BM, Cawthray JF, Lewis JS, Adam MJ, Orvig C. What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistry. Inorg Chem 2014;53:10412-31. [PMID: 25192223 DOI: 10.1021/ic501466z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
64 Bernard-Gauthier V, Wängler C, Schirrmacher E, Kostikov A, Jurkschat K, Wängler B, Schirrmacher R. ¹⁸F-labeled silicon-based fluoride acceptors: potential opportunities for novel positron emitting radiopharmaceuticals. Biomed Res Int 2014;2014:454503. [PMID: 25157357 DOI: 10.1155/2014/454503] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
65 Deri MA, Ponnala S, Zeglis BM, Pohl G, Dannenberg JJ, Lewis JS, Francesconi LC. Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO). J Med Chem 2014;57:4849-60. [PMID: 24814511 DOI: 10.1021/jm500389b] [Cited by in Crossref: 115] [Cited by in F6Publishing: 121] [Article Influence: 12.8] [Reference Citation Analysis]
66 Chang CJ, Raymond KN. Preface for the forum on imaging and sensing: probing and utilizing the elements of life for studying and improving health and society. Inorg Chem 2014;53:1791-3. [PMID: 24506438 DOI: 10.1021/ic500099n] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
67 Bottorff SC, Kasten BB, Stojakovic J, Moore AL, MacGillivray LR, Benny PD. Cu-free 1,3-dipolar cycloaddition click reactions to form isoxazole linkers in chelating ligands for fac-[M(I)(CO)3]+ centers (M = Re, 99mTc). Inorg Chem 2014;53:1943-5. [PMID: 24483834 DOI: 10.1021/ic402825t] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
68 Foerster C, Knight JC, Wuest M, Rowan B, Lapi SE, Amoroso AJ, Edwards PG, Wuest F. Synthesis, complex stability and small animal PET imaging of a novel 64 Cu-labelled cryptand molecule. Med Chem Commun 2014;5:958-62. [DOI: 10.1039/c4md00174e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]